Related Experiment Video
Updated: Feb 23, 2026
06:03
Oropharyngeal Administration of Bleomycin in the Murine Model of Pulmonary Fibrosis
Published on: May 9, 2025
1.9K
Primary pulmonary MALT lymphoma presenting as non-resolving pneumonia
Asma Iftikhar1, Albert Magh, Muhammed Azaz Cheema
1New York Presbyterian Hospital Queens Department of Pulmonary, Critical Care and Sleep Medicine 56-45 Main Street. Flushing, NY 11355. doctorasmi@gmail.com.
Advances in Respiratory Medicine
|September 6, 2017
Summary
Primary pulmonary MALT lymphoma is a rare lung disorder often misdiagnosed as pneumonia. Early consideration in non-resolving pneumonia cases is crucial for accurate diagnosis and timely treatment.
Area of Science:
- Pulmonology
- Oncology
- Pathology
Background:
- Primary lung lymphoma (PLL) is a rare condition affecting the lungs.
- Diagnosis is challenging due to non-specific clinical and radiological findings.
- Often misdiagnosed as pneumonia or lung tumors.
Observation:
- This case involves an 84-year-old patient.
- The patient presented with symptoms mimicking non-resolving pneumonia.
- Primary pulmonary MALT lymphoma was ultimately diagnosed.
Findings:
- Primary lung lymphoma is most commonly a mucosa-associated lymphoid tissue (MALT) lymphoma.
- MALT lymphoma is an extranodal low-grade B-cell lymphoma.
- The lungs are an uncommon site for MALT lymphoma, typically found in the gastrointestinal tract.
Implications:
- PLL should be included in the differential diagnosis for persistent pneumonia.
- Accurate diagnosis of pulmonary MALT lymphoma requires high clinical suspicion.
- Further research may improve diagnostic strategies for rare lung lymphomas.
Related Concept Videos
01:28Pulmonary Tuberculosis II
1.7K
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
1.7K
01:30Pneumonia I: Introduction
982
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
982
01:29Pneumonia II: Pathophysiology
3.4K
The pathophysiology of pneumonia involves the following steps:
3.4K
01:30Pneumonia III: Complications and Assessment
954
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
954
01:31Pulmonary Tuberculosis III
1.2K
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
1.2K
01:28Pneumonia IV: Management
855
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
855